Comparative risk of serious hypoglycemia with oral antidiabetic monotherapy: A retrospective cohort study Academic Article uri icon

Overview

MeSH Major

  • Bias (Epidemiology)
  • Confounding Factors (Epidemiology)
  • Data Interpretation, Statistical
  • Outcome Assessment (Health Care)
  • Research Design

abstract

  • Sulfonylureas were associated with the highest rates of serious hypoglycemia. Among all study drugs, the highest rate was seen with glyburide. Pioglitazone was associated with a lower adjusted hazard for serious hypoglycemia vs metformin, while rosiglitazone and nateglinide had hazards similar to that of metformin.

publication date

  • January 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/pds.4337

PubMed ID

  • 29108130

Additional Document Info

start page

  • 9

end page

  • 18

volume

  • 27

number

  • 1